Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.

Capsule production is common among bacterial species, but relatively rare in eukaryotic microorganisms. Members of the fungal Cryptococcus genus are known to produce capsules, which are major determinants of virulence in the highly pathogenic species Cryptococcus neoformans and Cryptococcus gattii....

Full description

Bibliographic Details
Main Authors: Glauber de S Araujo, Fernanda L Fonseca, Bruno Pontes, Andre Torres, Radames J B Cordero, Rosely M Zancopé-Oliveira, Arturo Casadevall, Nathan B Viana, Leonardo Nimrichter, Marcio L Rodrigues, Eloi S Garcia, Wanderley de Souza, Susana Frases
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22253734/pdf/?tool=EBI
id doaj-6e1defaef5e44778b1f374e05f9fde11
record_format Article
spelling doaj-6e1defaef5e44778b1f374e05f9fde112021-03-03T20:30:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0171e2956110.1371/journal.pone.0029561Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.Glauber de S AraujoFernanda L FonsecaBruno PontesAndre TorresRadames J B CorderoRosely M Zancopé-OliveiraArturo CasadevallNathan B VianaLeonardo NimrichterMarcio L RodriguesEloi S GarciaWanderley de SouzaSusana FrasesCapsule production is common among bacterial species, but relatively rare in eukaryotic microorganisms. Members of the fungal Cryptococcus genus are known to produce capsules, which are major determinants of virulence in the highly pathogenic species Cryptococcus neoformans and Cryptococcus gattii. Although the lack of virulence of many species of the Cryptococcus genus can be explained solely by the lack of mammalian thermotolerance, it is uncertain whether the capsules from these organisms are comparable to those of the pathogenic cryptococci. In this study, we compared the characteristic of the capsule from the non-pathogenic environmental yeast Cryptococcus liquefaciens with that of C. neoformans. Microscopic observations revealed that C. liquefaciens has a capsule visible in India ink preparations that was also efficiently labeled by three antibodies generated to specific C. neoformans capsular antigens. Capsular polysaccharides of C. liquefaciens were incorporated onto the cell surface of acapsular C. neoformans mutant cells. Polysaccharide composition determinations in combination with confocal microscopy revealed that C. liquefaciens capsule consisted of mannose, xylose, glucose, glucuronic acid, galactose and N-acetylglucosamine. Physical chemical analysis of the C. liquefaciens polysaccharides in comparison with C. neoformans samples revealed significant differences in viscosity, elastic properties and macromolecular structure parameters of polysaccharide solutions such as rigidity, effective diameter, zeta potential and molecular mass, which nevertheless appeared to be characteristics of linear polysaccharides that also comprise capsular polysaccharide of C. neoformans. The environmental yeast, however, showed enhanced susceptibility to the antimicrobial activity of the environmental phagocytes, suggesting that the C. liquefaciens capsular components are insufficient in protecting yeast cells against killing by amoeba. These results suggest that capsular structures in pathogenic Cryptococcus species and environmental species share similar features, but also manifest significant difference that could influence their potential to virulence.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22253734/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Glauber de S Araujo
Fernanda L Fonseca
Bruno Pontes
Andre Torres
Radames J B Cordero
Rosely M Zancopé-Oliveira
Arturo Casadevall
Nathan B Viana
Leonardo Nimrichter
Marcio L Rodrigues
Eloi S Garcia
Wanderley de Souza
Susana Frases
spellingShingle Glauber de S Araujo
Fernanda L Fonseca
Bruno Pontes
Andre Torres
Radames J B Cordero
Rosely M Zancopé-Oliveira
Arturo Casadevall
Nathan B Viana
Leonardo Nimrichter
Marcio L Rodrigues
Eloi S Garcia
Wanderley de Souza
Susana Frases
Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
PLoS ONE
author_facet Glauber de S Araujo
Fernanda L Fonseca
Bruno Pontes
Andre Torres
Radames J B Cordero
Rosely M Zancopé-Oliveira
Arturo Casadevall
Nathan B Viana
Leonardo Nimrichter
Marcio L Rodrigues
Eloi S Garcia
Wanderley de Souza
Susana Frases
author_sort Glauber de S Araujo
title Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
title_short Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
title_full Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
title_fullStr Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
title_full_unstemmed Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
title_sort capsules from pathogenic and non-pathogenic cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Capsule production is common among bacterial species, but relatively rare in eukaryotic microorganisms. Members of the fungal Cryptococcus genus are known to produce capsules, which are major determinants of virulence in the highly pathogenic species Cryptococcus neoformans and Cryptococcus gattii. Although the lack of virulence of many species of the Cryptococcus genus can be explained solely by the lack of mammalian thermotolerance, it is uncertain whether the capsules from these organisms are comparable to those of the pathogenic cryptococci. In this study, we compared the characteristic of the capsule from the non-pathogenic environmental yeast Cryptococcus liquefaciens with that of C. neoformans. Microscopic observations revealed that C. liquefaciens has a capsule visible in India ink preparations that was also efficiently labeled by three antibodies generated to specific C. neoformans capsular antigens. Capsular polysaccharides of C. liquefaciens were incorporated onto the cell surface of acapsular C. neoformans mutant cells. Polysaccharide composition determinations in combination with confocal microscopy revealed that C. liquefaciens capsule consisted of mannose, xylose, glucose, glucuronic acid, galactose and N-acetylglucosamine. Physical chemical analysis of the C. liquefaciens polysaccharides in comparison with C. neoformans samples revealed significant differences in viscosity, elastic properties and macromolecular structure parameters of polysaccharide solutions such as rigidity, effective diameter, zeta potential and molecular mass, which nevertheless appeared to be characteristics of linear polysaccharides that also comprise capsular polysaccharide of C. neoformans. The environmental yeast, however, showed enhanced susceptibility to the antimicrobial activity of the environmental phagocytes, suggesting that the C. liquefaciens capsular components are insufficient in protecting yeast cells against killing by amoeba. These results suggest that capsular structures in pathogenic Cryptococcus species and environmental species share similar features, but also manifest significant difference that could influence their potential to virulence.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22253734/pdf/?tool=EBI
work_keys_str_mv AT glauberdesaraujo capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT fernandalfonseca capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT brunopontes capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT andretorres capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT radamesjbcordero capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT roselymzancopeoliveira capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT arturocasadevall capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT nathanbviana capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT leonardonimrichter capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT marciolrodrigues capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT eloisgarcia capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT wanderleydesouza capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
AT susanafrases capsulesfrompathogenicandnonpathogeniccryptococcussppmanifestsignificantdifferencesinstructureandabilitytoprotectagainstphagocyticcells
_version_ 1714822139445510144